Psych360

Psych360 is a mental health technology company that operates a network of outpatient clinics providing ketamine-assisted therapy and psychedelic-informed psychiatric care to patients across the United States. Their platform combines clinical services with digital health tools designed to make these emerging therapeutic modalities more accessible and standardized across treatment settings. By bridging evidence-based psychedelic science with practical outpatient delivery, Psych360 aims to democratize access to treatments that have shown significant promise for treatment-resistant depression, anxiety, and other mental health conditions that traditional pharmaceuticals have failed to adequately address.

Psych360 has established itself as a growing player in the mental health technology space through its multi-clinic network model and vertically integrated approach to ketamine-assisted therapy delivery. The company combines clinical expertise with digital infrastructure to create a repeatable, scalable model for psychedelic-informed care, positioning itself to capture market share as regulatory pathways expand and clinical demand grows for novel psychiatric treatments. Their infrastructure supports both in-clinic experiences and remote monitoring capabilities, allowing them to serve geographically dispersed patient populations while maintaining clinical quality and safety standards.

Psych360's significance to the neurotech industry lies in its role as a bridge between cutting-edge neuroscience research and real-world clinical implementation at scale. As the psychedelic therapeutics field matures, companies that can combine rigorous clinical delivery with accessible digital platforms will be critical to translating scientific breakthroughs into meaningful patient outcomes. By demonstrating that ketamine-assisted therapy and psychedelic-informed care can be delivered safely and effectively across multiple outpatient settings, Psych360 contributes to validating these treatments' place in mainstream psychiatric practice and reducing the treatment gap for millions of Americans with mental health conditions.